Cohort profile for the MASTERMIND study: Using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes

BMJ Open

Volumn 7, Issue 10, 2017, Pages

  Rodgers, Lauren R ^a   Weedon, Michael N ^a   Henley, William E ^a   Hattersley, Andrew T ^b   Shields, Beverley M ^a  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

cohort studies; electronic medical records; general diabetes; hypoglycaemic agents; primary health care

Indexed keywords

HEMOGLOBIN A1C; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; METFORMIN; SULFONYLUREA DERIVATIVE;

ARTICLE; BODY MASS; CLINICAL PRACTICE; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT RESPONSE; ADULT; AGED; BLOOD; BODY WEIGHT; DATA BASE; DISEASE EXACERBATION; ELECTRONIC HEALTH RECORD; FEMALE; MALE; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; BODY MASS INDEX; BODY WEIGHT; DATABASES AS TOPIC; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; ELECTRONIC HEALTH RECORDS; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; METFORMIN; MIDDLE AGED; RETROSPECTIVE STUDIES; SULFONYLUREA COMPOUNDS; TREATMENT OUTCOME;

EID: 85031328882     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-017989     Document Type: Article

References (18)

1. National Institute for Health and Care Excellence. Type 2 diabetes in adults: Management. NICE guideline 2015.
2. Jones AG, McDonald TJ, Shields BM, et al. Markers of-cell failure predict poor glycemic response to GLP-1 receptor agonist therapy in type 2 diabetes. Diabetes Care 2016;39:150258.
3. Cantrell RA, Alatorre CI, Davis EJ, et al. A review of treatment response in type 2 diabetes: Assessing the role of patient heterogeneity. Diabetes Obes Metab 2010;12:845-57.
4. Williams T, van Staa T, Puri S, et al. Recent advances in the utility and use of the general practice research database as an example of a UK primary care data resource. Ther Adv Drug Saf 2012;3:89-99.
5. MHRA. Release Notes-CPRD GOLD, 2017.
6. PLOS Medicine Editors. Observational studies: Getting clear about transparency. PLoS Med 2014;11:e1001711.
7. Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: Enabling reuse for clinical research. J Am Med Inform Assoc 2013;20:144-51.
8. Springate DA, Kontopantelis E, Ashcroft DM, et al. ClinicalCodes: An online clinical codes repository to improve the validity and reproducibility of research using electronic medical records. PLoS One 2014;9:e99825.
9. Dave S, Petersen I. Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf 2009;18:704-7.
10. Schuemie MJ, Ryan PB, DuMouchel W, et al. Interpreting observational studies: Why empirical calibration is needed to correct p-values. Stat Med 2014;33:209-18.
11. Etminan M. Reporting guidelines for pharmacoepidemiological studies are urgently needed. BMJ 2014;349:g5511.
12. Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med 2015;12:e1001885.
13. Seidu S, Davies MJ, Mostafa S, et al. Prevalence and characteristics in coding, classification and diagnosis of diabetes in primary care. Postgrad Med J 2014;90:13-17.
14. Kontopantelis E, Parisi R, Springate DA, et al. Longitudinal multiple imputation approaches for body mass index or other variables with very low individual-level variability: The mibmi command in Stata. BMC Res Notes 2017;10:41.
15. Cohen HW, Shmukler C, Ullman R, et al. Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c). Diabet Med 2010;27:210-6.
16. Farmer AJ, Rodgers LR, Lonergan M, et al. Adherence to oral glucose-lowering therapies and associations with 1-year HbA1c: A retrospective cohort analysis in a large primary care database. Diabetes Care 2016;39:258-63.
17. Streeter AJ, Lin NX, Crathorne L, et al. Adjusting for unmeasured confounding in nonrandomized longitudinal studies: A methodological review. J Clin Epidemiol 2017;87:23-34.
18. Tannen RL, Weiner MG, Xie D. Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: Comparison of database and randomised controlled trial findings. BMJ 2009;338:b81.